2016
DOI: 10.2298/vsp141020072t
|View full text |Cite
|
Sign up to set email alerts
|

Kartagener’s syndrome: A case report

Abstract: Treatment for patients with this syndrome has not been established yet, but it is important to control chronic lung infections and prevent declining of lung function.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 10 publications
(9 reference statements)
0
2
0
Order By: Relevance
“…Primary ciliary dyskinesia (PCD) is a group of autosomal recessive disorders, and the subgroup that presents with the triad of sinusitis, bronchiectasis, and dextrocardia is called Kartagener's syndrome (KS). 1 Described by Kartagener in 1933, 2 this syndrome has an incidence of1-2/30,000 birth 3 and is seen in 40% to 50% of patients with PCD. 4 The ciliary dyskinesia and ineffective mucociliary clearance affect many tissues and organs such as the nasal mucosa and paranasal sinuses.…”
Section: Introductionmentioning
confidence: 99%
“…Primary ciliary dyskinesia (PCD) is a group of autosomal recessive disorders, and the subgroup that presents with the triad of sinusitis, bronchiectasis, and dextrocardia is called Kartagener's syndrome (KS). 1 Described by Kartagener in 1933, 2 this syndrome has an incidence of1-2/30,000 birth 3 and is seen in 40% to 50% of patients with PCD. 4 The ciliary dyskinesia and ineffective mucociliary clearance affect many tissues and organs such as the nasal mucosa and paranasal sinuses.…”
Section: Introductionmentioning
confidence: 99%
“…The main treatment goals are to prevent the progression of the disease, preserve pulmonary function, and improve quality of life. Standard treatment for sinopulmonary infections in KS includes mucolytics, bronchodilators, antibiotics, and chest physiotherapy 17. In patients with frequent exacerbations of bronchiectasis (≥3 times/year), a long-term low-dose prophylactic antibiotic is required.…”
mentioning
confidence: 99%